AnuMed International, LLC
Has AnuMed International, LLC received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued AnuMed International, LLC a warning letter naming semaglutide, dated Aug 20, 2024, with the FDA subject line “Finished Pharmaceutical/Unapproved New Drug/Adulterated/Misbranded.”
FDA records in this index name AnuMed International, LLC on Aug 20, 2024.
- Websites the letters name
- anumed-intl.com (see how each letter refers to them)
- Type named in FDA records
- Not stated
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide
- Latest record
- Aug 20, 2024
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Aug 20, 2024 | Finished Pharmaceutical/Unapproved New Drug/Adulterated/Misbranded | Semaglutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Aug 20, 2024: … and April 2024 and has observed that your website offers “ Semaglutide Homeopathic Formula,” “Magnesium 50 mg Body … during FDA’s inspection and on your website, your “ Semaglutide Homeopathic Formula,” “Magnesium 50 mg Body … drugs include, but may not be limited to, the following: Semaglutide Homeopathic Formula On the product label: • … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- anumed-intl.com: FDA’s warning letter of Aug 20, 2024 is addressed to AnuMed International, LLC. It refers to the site in these words: “FDA also reviewed your website at the Internet address https://www.anumed-intl.com/ in February and April 2024 and has observed that your website offers “Semaglutide Homeopathic Formula,” “Magnesium 50 mg Body Cream,” …” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.